Pacer Advisors
BSX icon

Pacer Advisors’s Boston Scientific BSX Stock Holding History

Pacer Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.66M Sell
74,241
-50,890
-41% -$4.07M 0.01% 638
2025
Q4 		$11.9M Sell
125,131
-9,967
-7% -$977K 0.03% 452
2025
Q3 		$13.2M Sell
135,098
-17,945
-12% -$1.86M 0.03% 406
2025
Q2 		$16.4M Buy
153,043
+41,005
+37% +$4.15M 0.04% 368
2025
Q1 		$11.3M Sell
112,038
-26,019
-19% -$2.62M 0.03% 451
2024
Q4 		$12.3M Buy
138,057
+24,754
+22% +$2.18M 0.03% 413
2024
Q3 		$9.49M Sell
113,303
-8,450
-7% -$666K 0.02% 478
2024
Q2 		$9.38M Sell
121,753
-27,758
-19% -$2.03M 0.02% 446
2024
Q1 		$10.2M Sell
149,511
-29,128
-16% -$1.87M 0.02% 420
2023
Q4 		$10.3M Buy
178,639
+79,168
+80% +$4.23M 0.03% 399
2023
Q3 		$5.25M Buy
99,471
+1,871
+2% +$98.1K 0.02% 460
2023
Q2 		$5.28M Buy
97,600
+10,075
+12% +$526K 0.02% 518
2023
Q1 		$4.38M Buy
87,525
+82,369
+1,598% +$3.88M 0.02% 570
2022
Q4 		$239K Sell
5,156
-11,588
-69% -$502K ﹤0.01% 2022
2022
Q3 		$648K Sell
16,744
-1,275
-7% -$51.1K ﹤0.01% 661
2022
Q2 		$672K Sell
18,019
-55,202
-75% -$2.25M 0.01% 620
2022
Q1 		$3.24M Sell
73,221
-2,405
-3% -$104K 0.03% 503
2021
Q4 		$3.21M Sell
75,626
-15,348
-17% -$645K 0.03% 620
2021
Q3 		$3.95M Buy
90,974
+1,465
+2% +$64.8K 0.05% 494
2021
Q2 		$3.83M Buy
89,509
+11,439
+15% +$481K 0.05% 436
2021
Q1 		$3.02M Sell
78,070
-7,957
-9% -$301K 0.05% 403
2020
Q4 		$3.09M Sell
86,027
-25,056
-23% -$903K 0.06% 328
2020
Q3 		$4.24M Sell
111,083
-19,846
-15% -$765K 0.09% 171
2020
Q2 		$4.6M Buy
+130,929
New +$4.72M 0.09% 164
2020
Q1 		– Sell
-161,188
Closed -$7.29M – 721
2019
Q4 		$7.29M Buy
161,188
+4,830
+3% +$202K 0.33% 49
2019
Q3 		$6.36M Buy
156,358
+20,342
+15% +$862K 0.14% 129
2019
Q2 		$5.85M Buy
136,016
+12,526
+10% +$482K 0.14% 118
2019
Q1 		$4.74M Buy
+123,490
New +$4.72M 0.13% 137
2018
Q4 		– Sell
-72,860
Closed -$2.81M – 602
2018
Q3 		$2.81M Buy
72,860
+9,533
+15% +$333K 0.11% 197
2018
Q2 		$2.07M Buy
63,327
+10,680
+20% +$322K 0.09% 260
2018
Q1 		$1.44M Buy
52,647
+5,889
+13% +$160K 0.08% 316
2017
Q4 		$1.16M Buy
46,758
+19,044
+69% +$525K 0.08% 351
2017
Q3 		$808K Buy
27,714
+2,612
+10% +$72.1K 0.07% 404
2017
Q2 		$696K Buy
25,102
+1,940
+8% +$51.5K 0.07% 418
2017
Q1 		$576K Buy
23,162
+733
+3% +$17.8K 0.07% 415
2016
Q4 		$485K Sell
22,429
-134
-0.6% -$2.92K 0.07% 418
2016
Q3 		$537K Buy
22,563
+776
+4% +$18.5K 0.08% 332
2016
Q2 		$509K Buy
21,787
+1,619
+8% +$35K 0.08% 323
2016
Q1 		$379K Buy
20,168
+1,461
+8% +$25.7K 0.09% 243
2015
Q4 		$345K Buy
+18,707
New +$335K 0.08% 255

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pacer Advisors's BSX Position: Q1 2026 in Review

Pacer Advisors reduced its Boston Scientific (BSX) stake by 41% in Q1 2026, selling an estimated $4.07M and leaving 74,241 shares worth $4.66M. The position accounts for 0.01% of the portfolio, ranked #638.

Pacer Advisors first reported a position in BSX in Q4 2015 and has held it in 40 quarters since. The position peaked at $16.4M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Pacer Advisors held 74,241 shares of Boston Scientific worth $4.66M as of Q1 2026.
  • Pacer Advisors sold 50,890 Boston Scientific shares in Q1 2026, an estimated $4.07M.
  • Boston Scientific made up 0.01% of Pacer Advisors's portfolio in Q1 2026, its #638 holding.
  • Pacer Advisors first reported a position in Boston Scientific in Q4 2015 and has held it in 40 quarters since.
  • Pacer Advisors's Boston Scientific position peaked at $16.4M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.